Triazole Benzene Sulfonamides as Leads for Human Carbonic Anhydrase IX Inhibition: Updates on Research Progress | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.


Triazole Benzene Sulfonamides as Leads for Human Carbonic Anhydrase IX Inhibition: Updates on Research Progress

Author(s): Papichettypalle Gopinath*

Introduction: Triazole moiety is considered as the most important heterocyclic therapeutic agent in medicinal chemistry. Identifying a lead compound or potential drug, with the requisite physical and biological characteristics from a library of known bioactive molecules is the first step in the traditional drug development process which involves identifying the protein target associated with the disease. This severely restricts the search space from the outset and makes the task of discovering new drugs (or novel chemical structures) very challenging.

Areas covered: This review discusses triazole derivatives possessing anticancer activity (hCA inhibition) and also illustrates the recent updates on triazole moiety for hCA inhibition research emphasizing the structure activity relationship aspects.

Conclusion: However, as the cellular and molecular causes of numerous diseases are better understood, more opportunities for logical therapeutic development broaden. Small molecule inhibitors of hCA IX interactions can now be found through screenings using large virtual chemical libraries and a series of novel compounds from research literature. In this context, the literature's triazole benzene sulfonamide derivatives have been thoroughly studied for structure-activity relationship and reported here for future design and development of leads.

Full-Text PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 25868

Der Pharma Chemica received 25868 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry